RxDoctor Payments Data

Susan Marcotte, DO

Family Medicine · Orland Park, ILNPI 1184678377

Payments from drug & device makers

$9,745in general payments, 2019–2025

Across 491 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$824
  • Pfizer$782
  • Johnson & Johnson$470
  • Amarin Pharma, Inc.$454
  • plus $5K from 32 others

What the payments were for

  • Consulting fees$1752%
  • Food & beverage$9,45297%
  • Education$1181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,745 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$89,043
Medicare patients
214
Services billed
1,014

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$34,915
JardianceEmpagliflozin21$26,418
JanumetSitagliptin Phos/Metformin Hcl13$20,173
MounjaroTirzepatide17$19,914
FarxigaDapagliflozin Propanediol11$17,135
JanuviaSitagliptin Phosphate26$16,013
OzempicSemaglutide11$12,021
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$6,245
Atorvastatin Calcium460$5,470
Levothyroxine Sodium298$4,519
Pantoprazole Sodium241$3,721
Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid22$2,818
Losartan Potassium216$2,506
SynthroidLevothyroxine Sodium36$2,322
Celecoxib69$2,161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet, Januvia$98$36,18639 claims
PfizerEliquis$782$34,91543 claims
Boehringer IngelheimJardiance$318$26,41821 claims
Lilly USA, LLCMounjaro$401$19,91417 claims
AstraZenecaFarxiga$1,284$17,13511 claims
Novo NordiskOzempic$411$12,02111 claims
GSKAnoro Ellipta$428$6,24511 claims
AbbVieSynthroid$1,326$2,32236 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Orland Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →